• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
JXSL0800001 人源抗-TNFα单克隆抗体(CNTO148)注射剂 golimumab Injection Biological Products(1) Import Drug Application 2008-01-15 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd Certificate Issued 2009-04-08 view
JXSL1000057 人源抗-TNFα单克隆抗体(CNTO 148)注射剂 golimumab Injection Biological Products Import Drug Application 2010-12-17 Centocor B.V. Centocor BV Certificate Issued 2013-11-15 view
JXSL1200051 戈利木单抗注射液 golimumab Injection Biological Products Import Drug Application 2012-07-09 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2014-07-24 view
JXSS1400007 CNTO 148单抗注射液 golimumab Injection Biological Products Import Drug Application 2014-07-17 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-01-04 view
JXSR1400001 戈利木单抗注射液 golimumab Injection Biological Products State Standards 2014-09-25 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-04-25 view
JXSL1500061 戈利木单抗静脉注射液 golimumab Injection Biological Products Import Drug Application 2015-10-28 JANSSEN INC. Janssen Inc Certificate Issued 2017-05-11 view
JYSB1800033 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2018-03-02 Janssen Biologics B.V. Janssen Biologics BV Filed 2018-03-18 view
JYSB1800120 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2018-06-04 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2018-07-26 view
JYSB1800200 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2018-09-29 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2019-05-06 view
JYSB1900121 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2019-05-31 Janssen Biologics B.V. Janssen Biologics BV Filed 2019-06-11 view
JYSB1900115 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2019-06-03 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2020-02-27 view
JYSB1900231 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2019-09-04 Janssen Biologics B.V. Janssen Biologics BV Certificate Issued 2020-08-18 view
JYSB2000334 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2020-06-28 Janssen Biologics B.V. Janssen Biologics BV Filed 2020-07-01 view
JYSB2000679 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2020-12-28 Janssen Biologics B.V. Janssen Biologics BV In Review 2022-01-27 view
JYSB2000678 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2020-12-28 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd Certificate Issued 2021-12-17 view
JYSB2100063 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2021-02-26 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd Certificate Issued 2021-12-24 view
JYSB2100062 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2021-02-26 西安杨森制药有限公司 Xian Janssen Pharmaceutical Ltd Certificate Issued 2021-12-24 view
JYSB2100090 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2021-04-01 Janssen Biologics B.V. Janssen Biologics BV In Review 2021-03-31 view
JYSB2100089 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2021-04-01 Janssen Biologics B.V. Janssen Biologics BV In Review 2021-05-09 view
JYSB2101095 戈利木单抗注射液 golimumab Injection Biological Products Supplementary Application 2021-07-27 view